Meanwhile, two studies demonstrated that lidocaine inhibited cancer migration and enhanced the efficacy of the cyclin-dependent kinase 4/6 inhibitor palbociclib in TNBC [12,53]. The gene discussed is CDK4; the disease is cancer.